B. Braun Spain has requested delivery of their first DrugLog system. The delivery is a result of a large launch campaign initiated by B. Braun.
Since the signing of the partnership agreement in early 2018, Pharmacolog and B. Braun Spain have prepared the launch of DrugLog and PrepLog in the Spanish-speaking market. In the beginning of 2020, a first order was placed for two units, which were communicated in a press release on January 27 of the same year. Due to the pandemic, the launch campaign and the delivery of the first two systems were delayed. B. Braun is now carrying out a comprehensive launch campaign during the fall, which immediately resulted in the request for delivery of the first system.
Mats Högberg, CEO of Pharmacolog comments: “It is with great pleasure we now launch the campaign, delayed due to the pandemic, together with B. Braun. I am deeply impressed by the professionalism and long-term perspective that B. Braun demonstrates and look forward to our continued collaboration, which I am convinced will revolutionize the way the market looks at quality control in pharmaceutical preparation. Ultimately, our common focus is improved patient safety, meaning administration of the correct medication with the right concentration.”
Pharmacolog is specialized in developing systems and solutions for more effective and safer use of intravenous drugs. The company’s first product, DrugLog®, enables a nurse or pharmacist to quickly and easily verify that an injectable drug has the right identity and concentration. Pharmacolog’s long-term vision is an individually optimized medication for each individual patient, considering all available parameters in the control and distribution of the drug. Further information regarding the company is available at http://www.pharmacolog.com. The company’s Certified Adviser is Mangold Fondkommission AB, which can be reached on telephone number +46 8-5030 15 50 or through CA@mangold.se.